Posted: 2 November 2026 - Cambridge, United Kingdom
Join AstraZeneca as a Postdoctoral Fellow to explore how epigenetic changes contribute to resistance against targeted therapies in lung cancer. You will lead a three-year project, conducting experiments and analyzing data to uncover pathways behind resistance. Collaborate with experts and contribute to high-impact publications in a supportive environment.